Encoded Therapeutics is a private drug discovery company. It was valued at $1.8 billion at its Series F in Sep 2026, the last priced event on record. It has raised $275 million across 2 recorded rounds; the latest was a $275 million Series F in Sep 2026.
PMV mark · valuation
$1.8B
Oct 2026
Priced at
its Series F
Sep 2026
Total raised
$275.0M
Last round
Series F
Sep 2026
Cap table — not yet on record
Encoded Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Encoded Therapeutics with a free account
·The post-money valuation on its round
·Watch Encoded Therapeutics: the Monday email on marks, rounds and moves
Where does Encoded Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Encoded Therapeutics's 2 recorded funding rounds.
